PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia. Dr.bosaeed@live.com.\', \'College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Dr.bosaeed@live.com.\', \'King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. Dr.bosaeed@live.com.\', \'Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.\', \'King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.\', \'College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.\', \'Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.\', \'Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04825-x
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33129363
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all